Literature DB >> 29313277

Does Sleeve Shape Make a Difference in Outcomes?

Adel Alhaj Saleh1,2, Michal R Janik3,4, Rami R Mustafa3, Mohammed Alshehri3, Adil H Khan3, Seyed Mohammad Kalantar Motamedi3, Shiraz Rahim3, Indravadan Patel3, Amir Aryaie3,5, Mujjahid Abbas3, Tomasz Rogula3, Leena Khaitan6.   

Abstract

INTRODUCTION: Sleeve gastrectomy (SG) is one of the most common procedures performed for weight loss. Many seek the "perfect sleeve" with the notion that the type of calibrating device affects sleeve shape, and this in turn will affect outcomes and complications. Two major concerns after SG are amount of weight loss and acid reflux. Our aim was to determine if the various calibration methods could impact sleeve shape and thereby allow for better outcomes of weight loss and reflux.
METHODS: A retrospective chart review was performed of 210 patients who underwent SG and had postoperative upper gastrointestinal (UGI) study from 2011 to 2015 in a single center by a single (fellowship-trained) bariatric surgeon. Data regarding demographics, calibrating devices and clinical outcomes at 1 year (weight loss and de novo acid reflux) were collected. UGIs were reviewed by two radiologists blinded to the clinical outcomes. Sleeve shape was classified according to a previously described classification as tubular, dumbbell, upper pouch, or lower pouch. The types of calibrating devices used to guide the sleeve size intraoperatively were endoscopy, large-bore orogastric tube, and fenestrated suction tube.
RESULTS: One hundred ninety-nine patients met inclusion criteria (11 had no esophagram). Demographics revealed age 45.76 ± 10.6 years, BMI 47 ± 8.6 kg/m2, and 82% female. Calibration devices used were endoscopic guidance (7.6%), large bore orogastric tube (41.4%), and fenestrated suction tube (50.5%). Sleeve shape was reported as 32.6% tubular, 20.6% dumbbell, 39.2% lower pouch, and 7.5% upper pouch (100% interrater reliability). No correlation was seen with type of calibration used. Of patients, 62.0% had > 50% excess weight loss at 1 year. Twenty-three percent of patients remained on PPI at 1 year (of which 43.3% did not have reflux preoperatively). The lower pouch shape showed a trend toward less reflux and more weight loss.
CONCLUSION: This study showed no clear association between uniformity of sleeve shape and the type of calibration device used. The study showed a trend toward decreased reflux and improved weight loss with the lower pouch shape, regardless of calibration device.

Entities:  

Keywords:  Reflux; Shape; Sleeve gastrectomy; Weight loss

Mesh:

Year:  2018        PMID: 29313277     DOI: 10.1007/s11695-017-3087-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  18 in total

Review 1.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology.

Authors:  Juliana C N Chan; Vasanti Malik; Weiping Jia; Takashi Kadowaki; Chittaranjan S Yajnik; Kun-Ho Yoon; Frank B Hu
Journal:  JAMA       Date:  2009-05-27       Impact factor: 56.272

2.  Improvement of gastroesophageal reflux symptoms after standardized laparoscopic sleeve gastrectomy.

Authors:  Jorge Daes; Manuel E Jimenez; Nadim Said; Rodolfo Dennis
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

3.  Dilated upper sleeve can be associated with severe postoperative gastroesophageal dysmotility and reflux.

Authors:  Andrei Keidar; Liat Appelbaum; Chaya Schweiger; Ram Elazary; Aniceto Baltasar
Journal:  Obes Surg       Date:  2009-12-01       Impact factor: 4.129

4.  Standardized outcomes reporting in metabolic and bariatric surgery.

Authors:  Stacy A Brethauer; Julie Kim; Maher El Chaar; Pavlos Papasavas; Dan Eisenberg; Ann Rogers; Naveen Ballem; Mark Kligman; Shanu Kothari
Journal:  Obes Surg       Date:  2015-04       Impact factor: 4.129

5.  Shields M., Carroll M.D., Ogden C.L. adult obesity prevalence in Canada and the United States. NCHS data brief no. 56, Hyattsville, MD: National Center for Health Statistics, 2011.

Authors:  Shelley McGuire
Journal:  Adv Nutr       Date:  2011-06-28       Impact factor: 8.701

6.  The Impact of Different Surgical Techniques on Outcomes in Laparoscopic Sleeve Gastrectomies: The First Report from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP).

Authors:  Elizabeth R Berger; Ronald H Clements; John M Morton; Kristopher M Huffman; Bruce M Wolfe; Ninh T Nguyen; Clifford Y Ko; Matthew M Hutter
Journal:  Ann Surg       Date:  2016-09       Impact factor: 12.969

7.  Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome.

Authors:  Paul E Roa; Orit Kaidar-Person; David Pinto; Minyoung Cho; Samuel Szomstein; Raul J Rosenthal
Journal:  Obes Surg       Date:  2006-10       Impact factor: 4.129

8.  Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results.

Authors:  Crystine M Lee; Paul T Cirangle; Gregg H Jossart
Journal:  Surg Endosc       Date:  2007-03-14       Impact factor: 4.584

9.  Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels.

Authors:  F B Langer; M A Reza Hoda; A Bohdjalian; F X Felberbauer; J Zacherl; E Wenzl; K Schindler; A Luger; B Ludvik; G Prager
Journal:  Obes Surg       Date:  2005-08       Impact factor: 4.129

10.  Laparoscopic sleeve gastrectomy: a retrospective review of 1- and 2-year results.

Authors:  Moisés Jacobs; William Bisland; Eddie Gomez; Gustavo Plasencia; Raul Mederos; Carlos Celaya; Roberto Fogel
Journal:  Surg Endosc       Date:  2009-08-19       Impact factor: 4.584

View more
  2 in total

1.  Surgical management of gastroesophageal reflux disease in the obese patient.

Authors:  P Nau; H T Jackson; A Aryaie; A Ibele; D Shouhed; E Lo Menzo; M Kurian; L Khaitan
Journal:  Surg Endosc       Date:  2019-11-12       Impact factor: 4.584

Review 2.  Relationship between gastroesophageal reflux disease and laparoscopic sleeve gastrectomy: a narrative review.

Authors:  Flavius Mocian; Marius Coroș
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-02-26       Impact factor: 1.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.